The study of c-Src kinase and pStat3 protein expression in retinoblastoma

Experimental Eye Research

Volumn 83, Issue 4, 2006, Pages 736-740

  Mohan, Adithi ^a   Mallikarjuna, Kandalam ^a   Venkatesan, Nalini ^a   Abhyankar, Dhiraj ^b   Parikh, Purvish M ^c   Krishnakumar, Subramanian ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b Indian Co operative Oncology Network   (India)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

c Src kinase; immunohistochemistry; invasion; pStat3; retinoblastoma

Indexed keywords

C SRC TYROSINE KINASE; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RETINAL NEOPLASMS; RETINOBLASTOMA; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 33747594736     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.02.011     Document Type: Article

References (29)

1. Adithi M., Nalini V., and Krishnakumar S. The role of nitric oxide synthases and nitrotyrosine in retinoblastoma. Cancer 103 (2005) 1701-1711
2. Allred D.C., Clark G.M., Elledge R., Fuqua S.A., Brown R.W., Chamness G.C., Osborne C.K., and McGuire W.L. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl. Cancer Inst. 85 (1993) 200-206
3. AmirthaLakshmi S., Pushparaj V., Krishnamurthy V., Biswas J., Krishnakumar S., and Shanmugam M.P. Tetraspanin protein KAI1 expression in retinoblastoma. Br. J. Ophthalmol. 88 (2004) 593-595
4. Biswas J., Das D., Krishnakumar S., and Shanmugam M.P. Histopathological analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J. Pediatr. Ophthalmol. Strabismus 40 (2003) 265-267
5. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., and Darnell Jr. J.E. Stat3 as an oncogene. Cell 98 (1999) 295-303
6. Buettner R., Mora L.B., and Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin. Cancer Res. 8 (2002) 945-954
7. Conway R.M., Wheeler S.M., Murray T.G., Jockovich M.E., and O'Brien J.M. Retinoblastoma: animal models. Ophthalmol. Clin. North Am. 18 (2005) 25-39
8. Chevez-Barrios P., Hurwitz M.Y., Louie K., Marcus K.T., Holcombe V.N., Schafer P., Aguilar-Cordova C.E., and Hurwitz R.L. Metastatic and non-metastatic models of retinoblastoma. Am. J. Pathol. 157 (2000) 1405-1412
9. Cullinan A.E., and Brandt C.R. Cytokine induced apoptosis in human retinoblastoma cells. Mol. Vis. 10 (2004) 315-322
10. Finger P.T., Harbour J.W., and Karcioglu Z.A. Risk factors for metastasis in retinoblastoma. Surv. Ophthalmol. 47 (2002) 1-16
11. Folberg R., Salomao D., Grossniklaus H.E., Proia A.D., Rao N.A., and Cameron J.D. Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of tissues removed as part of the surgical treatment of common malignancies of the eye and its adnexa. Am. J. Surg. Pathol. 27 (2003) 999-1004
12. Gamero A.M., Young H.A., and Wiltrout R.H. Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer?. Cancer Cell 5 (2004) 111-112
13. Irby R.B., and Yeatman T.J. Role of Src expression and activation in human cancer. Oncogene. 19 (2000) 5636-5642
14. Ito H., Gardner-Thorpe J., Zinner M.J., Ashley S.W., and Whang E.E. Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Surgery 134 (2003) 221-226
15. Krishnakumar, AmirthaLakshmi S., Vanitha K., Shanmugam M.P., and Biswas J. nm23 expression in retinoblastoma. Ocul. Immunol. Inflamm. 12 (2004) 127-135
16. Krishnakumar S., Sundaram A., Abhyankar D., Krishnamurthy V., Shanmugam M.P., Gopal L., Sharma T., and Biswas J. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma. Cancer 100 (2004) 1059-1069
17. Krishnakumar S., Kandalam M., Mohan A., Iyer A., Venkatesan N., Biswas J., and Shanmugam M.P. Expression of Fas ligand in retinoblastoma. Cancer 101 (2004) 1672-1676
18. Krishnakumar S., Mohan A., Mallikarjuna K., Venkatesan N., Biswas J., Shanmugam M.P., and Ren-Heidenreich L. EpCAM expression in retinoblastoma: a novel molecular target for therapy. Invest. Ophthalmol. Vis. Sci. 45 (2004) 4247-4250
19. Krishnakumar S., Mallikarjuna K., Desai N., Muthialu A., Venkatesan N., Sundaram A., Khetan V., and Shanmugam M.P. Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. Br. J. Ophthalmol. 88 (2004) 1521-1526
20. Mohan A., Nalini V., Shanmugam M.P., Biswas J., and Krishnakumar S. Role of matrix metalloproteinases and their inhibitors in retinoblastoma. Invest. Ophthalmol. Vis. Sci. 46 (2005) E-Abstract 1107
21. Sahu S., Banavali S.D., Pai S.K., Nair C.N., Kurkure P.A., Motwani S.A., and Advani S.H. Retinoblastoma: problems and perspectives from India. Pediatr. Hematol. Oncol. 15 (1998) 501-508
22. Schultz K.R., Ranade S., Neglia J.P., and Ravindranath Y. An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India. Cancer 72 (1993) 282-286
23. Shanmugam M.P., Lakshmi A., Biswas J., and Krishnakumar S. Prognostic significance of Fas expression in retinoblastoma. Ocul. Immunol. Inflamm. 11 (2003) 107-113
24. Stiller C.A., and Parkin D.M. Geographic and ethnic variations in the incidence of childhood cancer. Br. Med. Bull. 52 (1996) 682-703
25. Wang T., Niu G., Kortylewski M., Burdelya L., Shain K., Zhang S., Bhattacharya R., Gabrilovich D., Heller R., Coppola D., Dalton W., Jove R., Pardoll D., and Yu H. Regulation of the innate and adaptive immune responses by STAT-3 signaling in tumor cells. Nat. Med. 10 (2004) 48-54
26. Xie T.X., Wei D., Liu M., Gao A.C., Ali-Osman F., Sawaya R., and Huang S. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene. 23 (2004) 3550-3560
27. Zimmerman L.E. Retinoblastoma and retinocytoma. In: Spencer W.H. (Ed). Ophthalmic Pathology. third ed. (1985), Saunders, San Francisco 1292-1351
28. Zhang S.S., Wei J.Y., Li C., Barnstable C.J., and Fu X.Y. Expression and activation of STAT proteins during mouse retina development. Exp. Eye Res. 76 (2003) 421-431
29. Zierhut M., Streilein J.W., Schreiber H., Jager M.J., Ruiter D., and Ksander B.R. Immunology of ocular tumours. Immunol. Today 20 (1999) 482-485